DanielWeissMD

PubMed

• 4 citations
  Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes.
  Erica M. Schulte, Peter W. Tuerk, Thomas A. Wadden, W. Timothy Garvey, Daniel Weiss, Kathie L. Hermayer, Louis J. Aronne, Lynne E. Becker, Ken Fujioka, Karen Miller-Ko...> ;International Journal of Obesity. 2020 Jan 1
• 18 citations
  Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled t...
  Lauren Holland-Carter, Peter W. Tuerk, Thomas A. Wadden, Ken Fujioka, Lynne E. Becker, Karen Miller-Kovach, Priscilla L. Hollander, W. Timothy Garvey, Daniel Weiss, Do...> ;Journal of Diabetes and Its Complications. 2017 May 1
• 32 citations
  Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes.
  Patrick M. O'Neil, Karen Miller-Kovach, Peter W. Tuerk, Lynne E. Becker, Thomas A. Wadden, Ken Fujioka, Priscilla L. Hollander, Robert F. Kushner, W. Timothy Garvey, D...> ;Obesity. 2016 Nov 1
• Lyme Disease.
  Daniel Weiss, Miriam F Weiss> ;Annals of Internal Medicine. 2016 Nov 1
• To the Editor: Starting insulin therapy.
  Daniel N. Weiss> ;Cleveland Clinic Journal of Medicine. 2015 Oct 1
• Diabetes therapy and cancer risk.
  Daniel N. Weiss> ;Cleveland Clinic Journal of Medicine. 2014 Dec 1
• A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
  Weiss, D. J.,Casaburi, R.,Flannery, R.,LeRoux-Williams, M.,Tashkin, D. P.> ;Chest. 2013 Jun
• Hyperhomocysteinemia in hypothyroidism.
  Daniel Weiss> ;Annals of Internal Medicine. 2000 Apr 18
• 1 citations
  Hyperglycemia during physical stress.
  Daniel Weiss> ;The American Journal of Medicine. 1996 Mar 1
• 64 citations
  Neoplastic pathology of oncogenic osteomalacia/rickets.
  Noel Weidner, Robert S. Bar, Daniel Weiss, M. Paul Strottmann> ;Cancer. 1985 Apr 15
• 13 citations
  Urethane-induced hepatic failure in man.
  Daniel Weiss, Rafael de los Santos> ;The American Journal of Medicine. 1960 Mar 1
• 16 citations
  Case reportCerebral mucormycosis
  Eleanor L. Long> ;The American Journal of Medicine. 1959 Apr 1
• Join now to see all

Journal Articles

• Bariatric surgery, vitamin C, and kidney stones.  
  Weiss, D, Cleveland Clinic J Med ; 77: 844
• Human Insulin, Drug Therapy Review.  
  Weiss, D, Iowa Medicine, Journal of the Iowa Medical Society; 74:116-118
• Oncogenic Osteomalacia: Strange Tumors in Strange Places.  
  Weiss, D., Bar, R.S. Weidner, N., Wener, M., Lee, F, Postgraduate Medical Journal; 61: 349-355
• Neoplastic Pathology of Oncogenic Osteomalacia/Rickets.  
  Weidner, N., Bar, R.S., Weiss, D., Strottmann, M.P, Cancer; 55: 1691-1705
• Oncogenic Osteomalacia.  
  Weiss, D., Bar, R.S., Weidner, N, Annals of Internal Medicine;102: 557
• Hyperglycemia During Physical Stress.  
  Weiss D, Amer J Med;100: 374
• Hyperhomocysteinemia in Hypothyroidism.  
  Weiss, D, Annals of Internal Med; 132: 677
• How to Help Your Patients Lose Weight: Current Therapy for Obesity.  
  Weiss, D, Cleveland Clinic J Med: 67: 739-54
• Acarbose for the prevention of diabetes.  
  Weiss D, Cleveland Clinic J Med; 70: 1088
• Management of Diabetes should be a team approach.  
  Weiss, D, American Family Physician; 75: 979
• Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes ACCORD trial.  
  Weiss, D, Am J Cardiol; 99 (12A): 56i-67i
• Effect of intensive treatment of hyperglycemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomized trial.  
  Weiss, D, Lancet; 376: 419-430
• Join now to see all

Abstracts/Posters

• Dietary Supplements, Nutraceuticals, and Functional Foods.
  Weiss, D., Mechanick J, Nutrition section of the 2011 edition of the American College of Endocrinology Self Assessment Prog

Lectures

• Insulin therapy and the use of insulin glargine. 
  Cleveland, OH
• Once monthly ibandronate for osteoporosis. 
  Multiple locations, 2005, 2006
• Update of the ACCORD Trial. Clinical implications of the ACCORD trial to the management of Type 2 Diabetes. 
  The Endocrinology Club, Beachwood, OH
• Case studies in osteoporosis. 
  Mentor, OH
• Byetta: The First Incretin Mimetic. 
  Local moderator for a national program presented by satellite. Cuyahoga Falls, OH
• A new insulin for the new millennium: Humalog Mix 75/25. 
  Cleveland, OH
• Insulin initiation. A Case study approach. 
  teleconference
• Insulin initiation and intensification. 
  Greater Northwest Ohio Diabetes Symposium, Findlay, OH
• Byetta: The First FDA-approved Incretin Mimetic. 
  Multiple locations, 2005, 2006
• The role of thiazolidinediones in the management of Type 2 Diabetes. 
  Marion, OH; Mansfield, OH
• Insulin analogue use to optimize glycemia in patients with diabetes. 
  Independence, OH
• Targeting lipids to reduce cardiovascular events; recent clinical trials. 
  Beachwood, OH
• Looking back, glancing forward: New approaches to dyslipidemia. 
  Beachwood, OH
• Rosuvastatin in treating hypercholesterolemia. 
  Mentor, OH
• Treating obesity and the use of orlistat. 
  Cleveland, OH
• In-Hospital glucose control. 
  Beachwood, OH
• Weight management in patients with co-morbid diseases. 
  Cleveland, OH
• Insights into the treatment of Type 2 Diabetes. 
  Multiple locations, 2002
• Tetanus. 
  Internal Medicine Grand Rounds, U of Iowa
• Collaboration and Clarity in Diabetes Care. 
  PDM Healthcare Expo. Cleveland, OH
• Management of obesity. 
  Erieside Clinic, Willoughby, OH
• Improving glycemic control in Type 2 Diabetes. 
  Cleveland Academy of Osteopathic Physicians. Beachwood, OH
• New therapies for 2 Diabetes: the incretin pathway. AND Practical applications of therapy for Type 2 Diabetes case discussions. 
  Lake Hospital System Diabetes Symposium, Eastlake, OH
• Treating insulin resistance in Type 2 Diabetes. 
  Cleveland, OH; Mayfield Heights, OH
• Aldosterone and Its Deficiency States. 
  Endocrinology-Metabolism Conference, U of Iowa
• Join now to see all